Publications

Found 97 results
Type [ Year(Asc)]
2011
CA Gersbach. "Engineered bioactive molecules." 5 (2011): 131-145.
CA Gersbach. "Engineered Proteins for Controlling Gene Expression." Principles of Regenerative Medicine (2011): 159-176.
T Gaj, AC Mercer, CA Gersbach, RM Gordley, and CF Barbas. "Structure-guided reprogramming of serine recombinase DNA sequence specificity." Proceedings of the National Academy of Sciences of USA 108, no. 2 (2011): 498-503.
T Gaj, AC Mercer, CA Gersbach, RM Gordley, and CFB III. "Structure-guided reprogramming of serine recombinase DNA sequence specificity." Proceedings of the National Academy of Sciences of USA 108, no. 2 (2011): 510-515.
CA Gersbach, T Gaj, RM Gordley, AC Mercer, and CF Barbas. "Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase." Nucleic Acids Research 39, no. 17 (2011): 7868-7878.
2010
CA Gersbach, T Gaj, RM Gordley, and CF Barbas. "Directed evolution of recombinase specificity by split gene reassembly." Nucleic Acids Research 38, no. 12 (2010): 4198-4206.
2009
RM Gordley, CA Gersbach, and CF Barbas. "Synthesis of programmable integrases." Proceedings of the National Academy of Sciences of USA 106, no. 13 (2009): 5053-5058.
2007
CA Gersbach,, JM Le Doux, and AJ García. "Biomaterial-mediated retroviral gene transfer using self-assembled monolayers." Biomaterials 28, no. 34 (2007): 5121-5127.
CA Gersbach, JE Phillips, and AJ García. "Genetic engineering for skeletal regenerative medicine." Annual Review of Biomedical Engineering 9 (2007): 87-119.
S Pregizer, A Barski, CA Gersbach, AJ García, and B Frenkel. "Identification of novel Runx2 targets in osteoblasts: cell type-specific BMP-dependent regulation of Tram2." Journal of Cellular Biochemistry 102, no. 6 (2007): 1458-1471.
CA Gersbach, RE Guldberg, and AJ García. "In vitro and in vivo osteoblastic differentiation of BMP-2- and Runx2-engineered skeletal myoblasts." Journal of Cellular Biochemistry 100, no. 5 (2007): 1324-1336.
JE Phillips, CA Gersbach, and AJ García. "Virus-based gene therapy strategies for bone regeneration." Biomaterials 28, no. 2 (2007): 211-229.
2006
JE Phillips, CA Gersbach, AM Wojtowicz, and AJ García. "Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation." Journal of cell science 119, no. Pt 3 (2006): 581-591.
CA Gersbach, JM Le Doux, RE Guldberg, and AJ García. "Inducible regulation of Runx2-stimulated osteogenesis." Gene Therapy 13, no. 11 (2006): 873-882.
2005
MA Lan, CA Gersbach, KE Michael, BG Keselowsky, and AJ García. "Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries." Biomaterials 26, no. 22 (2005): 4523-4531.
CA Gersbach, JE Phillips, RE Guldberg, and AJ García. "Runx2-genetically engineered cells for bone tissue engineering." Proceedings of the 2005 Summer Bioengineering Conference 2005 (2005): 603-604.
J Drevs, U Zirrgiebel, CIM Schmidt-Gersbach, K Mross, M Medinger, L Lee, J Pinheiro, J Wood, AL Thomas, C Unger et al. "Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials." Annals of Oncology 16, no. 4 (2005): 558-565.
2004
CA Gersbach, BA Byers, GK Pavlath, and AJ García. "Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype." Experimental Cell Research 300, no. 2 (2004): 406-417.
CA Gersbach. "Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype." Exp. Cell Res. 300 (2004): 406-417.
CA Gersbach, BA Byers, GK Pavlath, RE Guldberg, and AJ García. "Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro." Biotechnology & Bioengineering 88, no. 3 (2004): 369-378.
CA Gersbach, BA Byers, RE Guldberg, GK Pavlath, and AJ García. "Runx2-stimulated transdifferentiation of primary skeletal myoblasts into an osteoblastic mineralizing phenotype for bone tissue engineering." Transactions - 7th World Biomaterials Congress (2004).
2003
AJ García, RE Guldberg, BA Byers, CA Gersbach, and JE Phillips. "Addressing cell-sourcing limitations with gene therapy." IEEE Engineering in Medicine and Biology Magazine 22, no. 5 (2003): 65-70.

Pages